BPC-157 and TB-500 peptide claims: what the science supports

What did @landotalkspeps actually say?

The creator gave a broad overview of tesamorelin, calling it "a growth hormone secretagogue that works through growth hormone pathways to directly target visceral fat." They described a common dosing pattern of 1mg five to seven times per week, advised fasted administration, and outlined a cycle structure of 10 to 12 weeks on followed by four weeks off. They also flagged that carbohydrate consumption within one to two hours before or after injection would "blunt the signal of growth hormone release, making it completely useless." The framing throughout was practical and protocol-focused, aimed at people who are either already using tesamorelin or considering it.

To be fair, the creator added a lifestyle caveat at the end and included a brief disclaimer. But the video still functions as dosing guidance, which matters when we're talking about a compound with a real regulatory history and real side effect potential.

Does the science back this up?

Partially. Tesamorelin has stronger clinical evidence behind it than most peptides discussed on TikTok, but that evidence is narrow and the creator overstates how cleanly it translates to general wellness use.

Tesamorelin is an FDA-approved synthetic analog of growth hormone-releasing hormone (GHRH). It was approved in 2010 specifically for reducing excess abdominal fat in HIV-associated lipodystrophy, not for general body recomposition. The landmark trials by Falutz et al. (2010, New England Journal of Medicine) showed statistically significant reductions in visceral adipose tissue in that specific population after 26 weeks of daily 2mg subcutaneous injection. That is a different population, a different dose, and a different duration than what this video describes.

On the fasting claim: there is legitimate physiological reasoning here. Growth hormone secretion is suppressed by elevated insulin, and insulin rises after carbohydrate intake (Hartman et al., 1992, Journal of Clinical Endocrinology and Metabolism). So fasted administration does have a rationale. Calling carb consumption within that window "completely useless" is an overstatement, but the underlying logic is not invented.

What did they get wrong (or right)?

The creator gets credit for correctly identifying tesamorelin as a GHRH analog rather than growth hormone itself, a distinction a lot of peptide content gets completely wrong. They also correctly note it stimulates the pituitary, which is mechanistically accurate.

What they get wrong is more significant. First, describing tesamorelin as something that will help with "sleep, recovery, and muscle definition" generalizes well beyond what the clinical data actually demonstrates. The FDA-approved indication is specific. Benefits like improved sleep architecture or muscle definition in healthy, non-lipodystrophic adults are not established by controlled trials, they are extrapolated from GH axis pharmacology and anecdote.

Second, the 1mg dose presented as standard is lower than the FDA-studied 2mg dose. That is not automatically wrong, dose titration exists, but presenting any specific dose as "commonly used" without clinical context is the kind of thing that should be flagged. Tesamorelin can cause fluid retention, joint discomfort, glucose dysregulation, and potential IGF-1 elevation, none of which are mentioned.

What should you actually know?

Tesamorelin is not a general-purpose fat loss peptide with a clean safety record across healthy populations. It is a drug with an approved indication, studied in a specific patient group, with documented side effects that include elevated glucose and increased IGF-1, which carries its own long-term considerations.

The cycle structure described in the video (10 to 12 weeks on, four weeks off) has no grounding in published clinical trial design for tesamorelin. The Falutz trials ran 26 weeks continuously. The off-cycle rationale presented is standard peptide community convention, not evidence-based protocol design.

If you are interested in tesamorelin for any reason, that conversation belongs with a clinician who can order baseline IGF-1, assess metabolic markers, and determine whether the risk-benefit profile makes sense for your situation. A TikTok protocol is not a substitute for that evaluation, regardless of how confident the delivery sounds.